drugset / Trial / NCT05261464

Heart Rate Controller in Computed Tomography Coronary Angiography

NCT05261464

Phase 4 Unknown 246 enrolled Mahidol University
RandomizedFactorialTriple-blindTreatment

Summary

Coronary computed tomography angiography (CCTA) is one of important non-invasive test for diagnosis of coronary artery disease. Cardiac motion artifact by heart rate (HR) has impact on CCTA interpretation. Current recommendation suggests HR reduction at less than 60 bpm with using of oral metoprolol. However, there are populations that are contraindicated for beta blockers. There were scantly data of calcium channel blocker and ivabradine. Moreover, there is no data comparing these 3 drug groups within single trial This double-blinded randomized controlled trial compares oral metoprolol immediate release, diltiazem immediate release and ivabradine with primary endpoint of patients' percentage to achieve target HR lower than 60 bpm prior to CCTA.

Timeline

Start
2021-01-30
Primary completion
2022-06-20
Completion
2022-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Diltiazem Small molecule 30 mg Oral
Subject Ivabradine Small molecule 5 mg Oral
Comparator Metoprolol Other / unclassified 50 mg Oral

Indications

No indication recorded.